Â鶹ŮÀÉ Amyloidosis Project
A Fairfaxwood Health & Innovation Technology Initiative
About Amyloidosis
Amyloid proteins cause life-threatening diseases that can be present throughout the body, including the heart, kidneys, liver and brain. The most common localized form of amyloidosis is in the brain. Cerebral amyloidosis, when symptomatic, usually manifests in one of two ways: in Alzheimer's disease and related dementias and in stroke. Treatments are very limited and there are no cures. Because amyloid does not affect just one organ, unraveling the underlying cause of amyloid fibril creation – a hallmark of this disease – is complex and challenging. Â鶹ŮÀÉ's Charles E. Schmidt College of Medicine has started an important and timely conversation to bridge the gap between amyloid research and clinical practice.
Amyloidosis News
In the News
- 07/18/2024 - WLRN-NPR
- 08/09/2023 - Palm Beach Post
- 07/18/2023 - Sun Sentinel
- 07/14/2023 - Forbes
- 07/13/2023 - South Florida Hospital News and Healthcare Report
- 07/13/2023 - South Florida Business Journal
- 07/13/2023 - Â鶹ŮÀÉ Foundation, Inc.
Research
-
Amyloidosis and Amyloid-Related Diseases: Political Contexts of Early Discoveries
Turtz M, Bone BM, Ramos A, Dobbs M. Amyloidosis and Amyloid-Related Diseases: Political Contexts of Early Discoveries. Academic Medicine & Surgery. Published online October 10, 2025. -
A Punctuated Equilibrium Analysis of Amyloidosis (and Amyloid Related Diseases) in U.S. Policy Making
Turtz M, Dobbs M. A Punctuated Equilibrium Analysis of Amyloidosis (and Amyloid Related Diseases) in U.S. Policy Making. Academic Medicine & Surgery. Published online April 19, 2025. -
Cardiac Amyloidosis Trends in Relative Search Volume Data and Patient Safety.
Zervos S, Turtz M, Goldstein J, Dobbs M. Cardiac Amyloidosis Trends in Relative Search Volume Data and Patient Safety. Academic Medicine & Surgery. Published online February 3, 2026.